| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChiefDERIV | May 14 | D | 28,367 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChiefDERIV | May 14 | D | 35,472 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChiefDERIV | May 14 | D | 45,000 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChiefDERIV | May 14 | D | 50,974 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChiefDERIV | May 14 | D | 115,281 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChiefDERIV | May 14 | D | 82,500 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 45,220 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 27,320 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 9,754 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 5,645 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 41,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | A | 41,250 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 24,284 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | A | 24,284 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 45,220 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | A | 45,220 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | D | 22,610 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | A | 22,610 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | May 14 | U | 116,338 | — | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | Jan 28 | A | 45,220 | $0.00 | — |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | Jan 22 | S | 7,725 | $21.77 | $168K |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | Jan 20 | S | 2,203 | $19.79 | $44K |
| Apellis Pharmaceuticals, Inc. | APLS | Nur NicholsonChief | Jan 13 | S | 2,618 | $22.19 | $58K |